about
COMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson's disease (PD): relevance for motor and non-motor featuresNovel parkin mutations detected in patients with early-onset Parkinson's disease.Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses.Alexithymia in patients with Parkinson's disease treated with DBS of the subthalamic nucleus: a case-control studyOvert versus covert treatment for pain, anxiety, and Parkinson's disease.Expectation enhances autonomic responses to stimulation of the human subthalamic limbic region.On the role of dopamine replacement therapy in decision-making, working memory, and reward in Parkinson's disease: does the therapy-dose matter?Breakpoint mapping of 13 large parkin deletions/duplications reveals an exon 4 deletion and an exon 7 duplication as founder mutations.Emotion processing in Parkinson's disease: a three-level study on recognition, representation, and regulation.Impulsivities and Parkinson's disease: delay aversion is not worsened by Deep Brain Stimulation of the subthalamic nucleus.Modifications of the iron-neuromelanin system in Parkinson's disease.Alpha-synuclein and Parkinson's disease: a proteomic view.Motor outcomes in patients with advanced Parkinson's disease treated with levodopa/carbidopa intestinal gel in Italy: an interim analysis from the GREENFIELD observational study.The proteomic approach in Parkinson's disease.Continuous intestinal infusion of levodopa/carbidopa in advanced Parkinson's disease: efficacy, safety and patient selection.Characterization of the thalamic-subthalamic circuit involved in the placebo response through single-neuron recording in Parkinson patients.Genetic analysis of CHCHD2 and CHCHD10 in Italian patients with Parkinson's disease.Network Analysis Identifies Disease-Specific Pathways for Parkinson's Disease.Freezing and hypokinesia of gait induced by stimulation of the subthalamic region.Proteomic analysis of dopamine and α-synuclein interplay in a cellular model of Parkinson's disease pathogenesis.Changes in the two-dimensional electrophoresis pattern of the Parkinson's disease related protein DJ-1 in human SH-SY5Y neuroblastoma cells after dopamine treatment.Teaching neurons to respond to placebos.alpha-Synuclein protects SH-SY5Y cells from dopamine toxicity.Impulse control behaviors and subthalamic deep brain stimulation in Parkinson disease.Adaptive deep brain stimulation controls levodopa-induced side effects in Parkinsonian patients.Impulse control disorder and response-inhibition alterations in Parkinson's disease. A rare case of totally absent functionality of the medial-prefrontal cortex and review of literature.Electrophysiological properties of thalamic, subthalamic and nigral neurons during the anti-parkinsonian placebo response.Autonomic and emotional responses to open and hidden stimulations of the human subthalamic region.Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease.Lymphocyte proteomics of Parkinson's disease patients reveals cytoskeletal protein dysregulation and oxidative stress.Binding of anti-Parkinson's disease drugs to human serum albumin is allosterically modulated.Expectation modulates the response to subthalamic nucleus stimulation in Parkinsonian patients.Improvement of quality of life in patients with chronic inflammatory demyelinating polyneuropathy shifting from 16 to 20% subcutaneous immunoglobulins.Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy.Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson's disease.Effects of deep brain stimulation of the subthalamic nucleus on sleep architecture in parkinsonian patients.Medical therapy and subthalamic deep brain stimulation in advanced Parkinson's disease: a different long-term outcome?Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus.Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study.Transdermal apomorphine permeation from microemulsions: a new treatment in Parkinson's disease.
P50
Q24644555-4954A270-6EDA-4A9A-84FA-0050B287E27FQ33209648-EE0D21FC-296F-4D0B-AC41-7B34062A4B01Q34199513-4BAC3F67-36E0-42F8-B565-2A673DCB13FEQ34330232-78F5FB14-D2D3-4C7B-A55C-428E385AC658Q34359487-B5696B3F-2790-4DE0-A664-BBCA2C371F43Q34438613-19A78579-2CB9-4902-AAF3-C2D606211C69Q34981014-CB6D4800-6510-4B7C-BE51-337E008FFDCDQ35549433-7DF23B8B-A716-43D5-89C4-834BB3DBC507Q35673860-5143D7BB-3ADB-40B7-B299-7ED2618B7805Q36226872-ED11F0A4-F0E3-4D5C-9C8C-7A6F2A26726BQ36370608-36286600-DF71-4CB9-AD18-A00F0CEFEF82Q37157838-6B43C4EB-0CAF-4AF6-8EA1-A997B3044221Q37342303-A3075641-4DA6-48FB-B775-AA515C134209Q37817089-E67E7E88-217B-4E2B-9824-8B2133251A37Q38080952-B2DB7EF9-F624-47BE-A462-F81579B4A8DFQ38181287-89EE277E-E485-4D8E-B265-1DBA74513563Q39009321-AF5CDE30-5A76-44C6-BC28-70B4FF13E86CQ39076065-F45D83DE-179D-4DAA-A8EB-AAB4A235E4E7Q39336619-2D9EDB33-6F6A-4170-A0B9-0D532C14B125Q39639654-C0EAAE86-374B-4DB2-A82F-86F61CF41C51Q39656598-75DF306A-C5AC-4EF5-A67C-4B81D1ACD82AQ40009826-59B9DAE2-29A7-47C5-95C4-282B17FD4E7BQ40231449-D6462D03-55E6-4AE8-92FE-3A87A3C8714BQ40530060-CDF83925-EBC9-420C-B5D7-6243AC361022Q42356319-DBD0CBA7-7C22-4FAB-AC74-39A8B8304918Q42373452-249A7E63-604C-45E0-9A42-3B7DF8D62A79Q42455819-2D761C40-F9E4-4658-86A4-C667A784696AQ42627269-7AAC2F30-C153-449D-86C5-B632226A42FEQ42675021-2C9052D2-F2A7-45C6-ACCE-E0512EDDB7BCQ43061595-89937DCD-0F6C-4AFF-B919-1890B1E0A4AFQ43131930-3BB57B22-A45C-4589-ABB0-908340963580Q43738062-EF0E7C4E-8A14-4C13-8FB4-DAAB66D2D502Q43961509-1D2070DA-EE35-4677-A19B-0332A62C9F1AQ44520574-694F6D60-831A-4BD0-8F45-BA151991BE32Q44653366-08C05506-4C85-427D-9D5B-E20C10F58FB5Q44806615-F426534D-6018-43EA-A9E2-1D0A32233592Q44842920-E1F9940D-7610-4781-AD3F-E0CE579AB845Q44898080-99D6716E-E5D9-4D39-B5A1-30DE6A91561DQ44954147-5F44E02B-45DA-474B-85E4-3D63FE0E75BBQ45010962-56A6247A-1380-4EFD-A75D-1468195896B5
P50
name
Leonardo Lopiano
@ast
Leonardo Lopiano
@en
Leonardo Lopiano
@nl
type
label
Leonardo Lopiano
@ast
Leonardo Lopiano
@en
Leonardo Lopiano
@nl
prefLabel
Leonardo Lopiano
@ast
Leonardo Lopiano
@en
Leonardo Lopiano
@nl